Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT01217450
Brief Title:
Selumetinib and Cetuximab in Treating Patients With Refractory Solid Tumors
Official Title:
A Phase 1 Study of AZD6244 in Combination With Cetuximab in Refractory Solid Tumors
Study:
NCT01217450
Protocol Section:
NCT01217450